candesartan has been researched along with Stomach Neoplasms in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiotensin receptor blockers (ARBs; including candesartan, losartan, olmesartan and valsartan) are widely used to treat hypertension, heart failure and diabetic neuropathy." | 3.88 | Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study. ( Busby, J; Cardwell, CR; Hughes, C; Johnston, BT; McMenamin, Ú; Spence, A, 2018) |
| " The effects of AT1 receptor blocker candesartan were evaluated in a mouse model of peritoneal carcinomatosis." | 3.75 | Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin. ( Fujimura, T; Fujita, H; Fushida, S; Harada, S; Hirakawa, K; Kayahara, M; Kinami, S; Kinoshita, J; Ninomiya, I; Ohta, T; Yagi, Y; Yashiro, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busby, J | 1 |
| McMenamin, Ú | 1 |
| Spence, A | 1 |
| Johnston, BT | 1 |
| Hughes, C | 1 |
| Cardwell, CR | 1 |
| Okazaki, M | 1 |
| Fushida, S | 2 |
| Harada, S | 2 |
| Tsukada, T | 1 |
| Kinoshita, J | 2 |
| Oyama, K | 1 |
| Tajima, H | 1 |
| Ninomiya, I | 2 |
| Fujimura, T | 2 |
| Ohta, T | 2 |
| Yagi, Y | 1 |
| Fujita, H | 1 |
| Kinami, S | 1 |
| Kayahara, M | 1 |
| Yashiro, M | 1 |
| Hirakawa, K | 1 |
3 other studies available for candesartan and Stomach Neoplasms
| Article | Year |
|---|---|
Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Benzimidazoles; Biphen | 2018 |
The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents; Benzimidazoles; Biphenyl Co | 2014 |
Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Angiotensin II; A | 2009 |